Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 12559194)

Published in J Gastrointest Surg on January 01, 2003


Sharon M Weber1, Olcay Cubukcu-Dimopulo, J Alexander Palesty, Arief Suriawinata, David Klimstra, Murray F Brennan, Kevin Conlon

Author Affiliations

1: University of Wisconsin Hospital, Madison, Wisconsin, USA.

Articles citing this

Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch (2004) 3.04

Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25

Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95

Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J Gastroenterol (2007) 1.57

Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol (2009) 1.42

Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch (2004) 1.35

Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol (2010) 1.14

Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch (2009) 1.12

Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10

Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol (2013) 1.10

Autoimmune pancreatitis: a review. World J Gastroenterol (2007) 1.06

Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol (2007) 0.96

Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ (2006) 0.95

Pyogenic liver abscess after choledochoduodenostomy for biliary obstruction caused by autoimmune pancreatitis. World J Gastroenterol (2006) 0.92

Large vessel involvement by IgG4-related disease. Medicine (Baltimore) (2016) 0.92

Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis. Virchows Arch (2004) 0.90

Diagnosis and management of autoimmune pancreatitis: experience from China. World J Gastroenterol (2008) 0.88

Incidence and characteristics of chronic and lymphoplasmacytic sclerosing pancreatitis in patients scheduled to undergo a pancreatoduodenectomy. HPB (Oxford) (2010) 0.88

A practical approach to the diagnosis of autoimmune pancreatitis. World J Gastroenterol (2011) 0.86

Benign disease and unexpected histological findings after pancreaticoduodenectomy: the role of endoscopic ultrasound fine needle aspiration. Ann R Coll Surg Engl (2010) 0.86

Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol (2011) 0.85

Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol (2008) 0.84

Treatment and relapse of autoimmune pancreatitis. Gut Liver (2008) 0.82

Autoimmune pancreatitis: with special reference to a localized variant. J Med Ultrason (2001) (2008) 0.81

IgG₄-related sclerosing disease: a novel mimic of inflammatory bowel disease. Dig Dis Sci (2010) 0.81

Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol (2007) 0.81

Endoscopic ultrasound-guided fine needle aspiration in the differentiation of type 1 and type 2 autoimmune pancreatitis. World J Gastroenterol (2012) 0.80

Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT. Eur Radiol (2014) 0.79

T cell lymphoplasmacellular and eosinophilic infiltration of the pancreas with involvement of the gallbladder and duodenum in non-alcoholic duct-destructive chronic pancreatitis. Langenbecks Arch Surg (2004) 0.78

Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol (2008) 0.78

Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol (2013) 0.77

Autoantibodies in autoimmune pancreatitis. Int J Rheumatol (2012) 0.77

Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature. Rheumatol Int (2009) 0.75

Perspective: Lacrimal gland biopsy, is it important? Saudi J Ophthalmol (2009) 0.75

Increased Incidence of Benign Pancreatic Pathology following Pancreaticoduodenectomy for Presumed Malignancy over 10 Years despite Increased Use of Endoscopic Ultrasound. Diagn Ther Endosc (2014) 0.75

Autoimmune pancreatitis. Gland Surg (2016) 0.75

Hilar biliary obstruction: malignant masquerades. Semin Intervent Radiol (2007) 0.75

Autoimmune pancreatitis: a case report. Middle East J Dig Dis (2014) 0.75

Autoimmune pancreatitis in an Asian-dominant American population. Hawaii J Med Public Health (2012) 0.75

Sclerosing pancreatitis presenting as a periampullary tumour. HPB (Oxford) (2003) 0.75

Autoimmune pancreatitis: Multimodality non-invasive imaging diagnosis. World J Gastroenterol (2014) 0.75

[Spectrum of chronic pancreatitis. On the way to etiological classification]. Pathologe (2005) 0.75

Unexpected benign histopathology after pancreatoduodenectomy for presumed malignancy: accepting the inevitable. Langenbecks Arch Surg (2016) 0.75

Long-term surgical outcomes of patients with type 1 autoimmune pancreatitis. World J Surg (2013) 0.75

Articles by these authors

International network of cancer genome projects. Nature (2010) 20.35

Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 8.69

Clinicopathologic correlates of solitary fibrous tumors. Cancer (2002) 5.96

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res (2005) 5.44

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med (2011) 5.15

Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95

Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 4.79

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg (2003) 4.25

Quality of complication reporting in the surgical literature. Ann Surg (2002) 4.21

Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol (2002) 3.96

Pasireotide for postoperative pancreatic fistula. N Engl J Med (2014) 3.84

Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol (2002) 3.60

Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol (2003) 3.56

A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg (2006) 3.34

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg (2006) 3.23

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg (2008) 3.16

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer (2008) 3.10

Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg (2010) 2.99

Electronic synoptic operative reporting: assessing the reliability and completeness of synoptic reports for pancreatic resection. J Am Coll Surg (2010) 2.98

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer (2003) 2.96

Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg (2004) 2.86

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg (2004) 2.84

Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76

Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev (2006) 2.74

A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J (2005) 2.71

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg (2004) 2.62

Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma. J Am Coll Surg (2003) 2.54

Adult spermatic cord sarcomas: management and results. Ann Surg Oncol (2003) 2.52

Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg (2002) 2.47

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res (2002) 2.41

Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol (2002) 2.39

Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg (2005) 2.38

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg (2007) 2.37

Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol (2003) 2.36

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35

The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery (2002) 2.32

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res (2003) 2.32

Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience. J Urol (2006) 2.30

Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg (2013) 2.29

The value of splenic preservation with distal pancreatectomy. Arch Surg (2002) 2.27

American Surgical Association Blue Ribbon Committee Report on Surgical Education: 2004. Ann Surg (2005) 2.25

Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg (2012) 2.23

Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg (2007) 2.22

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19

Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol (2003) 2.18

Results after pancreatic resection for metastatic lesions. Ann Surg Oncol (2002) 2.15

Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol (2005) 2.12

Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg (2007) 2.12

Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol (2009) 2.10

Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol (2004) 2.09

Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08

Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05

Conventional hemangiopericytoma: modern analysis of outcome. Cancer (2002) 2.04

Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg (2010) 1.98

The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg (2004) 1.97

Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol (2002) 1.96

Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol (2003) 1.94

Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol (2003) 1.92

Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol (2002) 1.89

The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87

Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg (2007) 1.86

Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer (2002) 1.85

Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol (2010) 1.85

Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol (2007) 1.84

Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol (2004) 1.82

Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer (2002) 1.82

Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res (2003) 1.81

Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol (2004) 1.80

Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg (2004) 1.80

Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol (2002) 1.78

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg (2007) 1.75

Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol (2011) 1.75

Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg (2003) 1.74

Multiple primary soft tissue sarcomas. Cancer (2004) 1.73

Laparoscopic adrenalectomy for isolated adrenal metastasis. Ann Surg Oncol (2007) 1.71

Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol (2010) 1.70

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res (2009) 1.69

Management of primary liver sarcomas. Cancer (2007) 1.65

Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer (2010) 1.64

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64

A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res (2008) 1.64

Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol (2007) 1.64

Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol (2002) 1.62

Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection? J Am Coll Surg (2002) 1.62

Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. J Am Coll Surg (2012) 1.58

Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity. J Clin Oncol (2002) 1.58

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58

A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med (2003) 1.57

Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors. Clin Cancer Res (2007) 1.57

Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg (2003) 1.56

Extended local resection for advanced gastric cancer: increased survival versus increased morbidity. Ann Surg (2002) 1.55

The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg (2004) 1.55

Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer (2008) 1.53